InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,870.62
(
-1.32%
)
US TECH 100
19,936.80
(
0.37%
)
Dow Jones
43,444.99
(
-0.70%
)
Brent Oil
71.57
(
1.22%
)
Bitcoin
91,800.68
(
2.15%
)
Post# of 8473
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

quantumdot

Send PM Follow Ignore
Followers 6
Posts 671
Boards Moderated 0
Alias Born 07/19/2006

quantumdot

Re: docbanker post# 3687

Friday, 03/07/2008 10:08:34 AM

Friday, March 07, 2008 10:08:34 AM

Post# of 8473
He was joking. Jeez, for a smart guy you miss some pretty obvious cues.

Glad to see the company specifically address the dose selection for the PhIII in today's "newsy" PR. Just maybe some of the questions and discussion about dose selection that offended several on this board got through to the company? And just maybe they saw fit to address them, including the specific reference "These data also support the selection of the doses of 25 and 50 mg in our Phase 3 trials."

Perhaps open debate and dialogue of some of the issues can help surface extra information or clarification from the company. IMO, the defensive types on the board should embrace such posting threads rather than feel so threatened by them.

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RPRX News
More RPRX News
InvestorsHub NewsWire

Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM

HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM

Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM

Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM

Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM

Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!